FDA approves RFID device to locate breast lumps

The Food and Drug Administration approved Faxitron's device to identify breast lumps for removal prior to surgery.

Here are three things to know.

1. The Localizer is a wireless radiofrequency identification breast lesion localization system.

2. Clinicians can use the device to implant a mini RFID tag at the site of the breast lump up to 30 days prior to surgery.

3. The system includes a handheld mobile reader clinicians use to detect the tag within the breast.

More articles on supply chain:

Poll: GOP prioritizes lower drug prices over reducing government's role in healthcare
10 most-read supply chain stories in Apri
Supply chain tip of the week: Target services — not supplies — for cost savings

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Whitepapers

Featured Webinars